Morgan Stanley has issued a research report stating that, due to CHINA LIFE's strong new business value growth in the first quarter, it has raised its related growth assumptions. Consequently, the firm has slightly increased its profit forecasts for CHINA LIFE for 2026, 2027, and 2028 by 0.1%, 0.3%, and 0.4% respectively. Morgan Stanley has raised CHINA LIFE's price target by 2.6%, from HK$37.90 to HK$38.90, and maintains its "Overweight" rating.